Mexico Antiretroviral Therapy Market (2025-2031) | Size & Revenue, Trends, Value, Outlook, Share, Growth, Forecast, Industry, Companies, Segmentation, Competitive Landscape, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Mexico Country Macro Economic Indicators

3.2 Mexico Antiretroviral Therapy Market Revenues & Volume, 2021 & 2031F

3.3 Mexico Antiretroviral Therapy Market - Industry Life Cycle

3.4 Mexico Antiretroviral Therapy Market - Porter's Five Forces

3.5 Mexico Antiretroviral Therapy Market Revenues & Volume Share, By Class, 2021 & 2031F

3.6 Mexico Antiretroviral Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 Mexico Antiretroviral Therapy Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.8 Mexico Antiretroviral Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of HIV/AIDS in Mexico

4.2.2 Government initiatives to improve access to antiretroviral therapy

4.2.3 Technological advancements in antiretroviral drugs

4.3 Market Restraints

4.3.1 High cost associated with antiretroviral therapy

4.3.2 Stigma and discrimination against people living with HIV/AIDS

4.3.3 Limited healthcare infrastructure in certain regions of Mexico

6.1 Mexico Antiretroviral Therapy Market, By Class

6.1.1 Overview and Analysis

6.1.2 Mexico Antiretroviral Therapy Market Revenues & Volume, By Class, 2021- 2031F

6.1.3 Mexico Antiretroviral Therapy Market Revenues & Volume, By Nucleoside Reverse Transcriptase Inhibitors, 2021- 2031F

6.1.4 Mexico Antiretroviral Therapy Market Revenues & Volume, By HIV Protease Inhibitors, 2021- 2031F

6.1.5 Mexico Antiretroviral Therapy Market Revenues & Volume, By Non-nucleoside Reverse Transcriptase Inhibitors, 2021- 2031F

6.1.6 Mexico Antiretroviral Therapy Market Revenues & Volume, By Nucleotide Reverse Transcriptase Inhibitors, 2021- 2031F

6.1.7 Mexico Antiretroviral Therapy Market Revenues & Volume, By HIV Fusion Inhibitors, 2021- 2031F

6.1.8 Mexico Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F

6.2 Mexico Antiretroviral Therapy Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 Mexico Antiretroviral Therapy Market Revenues & Volume, By Oral, 2021- 2031F

6.2.3 Mexico Antiretroviral Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F

6.2.4 Mexico Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F

6.3 Mexico Antiretroviral Therapy Market, By End-Users

6.3.1 Overview and Analysis

6.3.2 Mexico Antiretroviral Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 Mexico Antiretroviral Therapy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.3.4 Mexico Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F

6.4 Mexico Antiretroviral Therapy Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 Mexico Antiretroviral Therapy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.4.3 Mexico Antiretroviral Therapy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.4.4 Mexico Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F

7.1 Mexico Antiretroviral Therapy Market Export to Major Countries

7.2 Mexico Antiretroviral Therapy Market Imports from Major Countries

8.1 Percentage of population with access to antiretroviral therapy

8.2 Number of healthcare facilities offering antiretroviral treatment

8.3 Research and development investment in new antiretroviral drugs

9.1 Mexico Antiretroviral Therapy Market Opportunity Assessment, By Class, 2021 & 2031F

9.2 Mexico Antiretroviral Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 Mexico Antiretroviral Therapy Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.4 Mexico Antiretroviral Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Mexico Antiretroviral Therapy Market Revenue Share, By Companies, 2024

10.2 Mexico Antiretroviral Therapy Market Competitive Benchmarking, By Operating and Technical Parameters